1 – 10 of 46
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities : further results from the prospective PANTHER study with focus on obese patients
2019) In Annals of oncology : official journal of the European Society for Medical Oncology 30(1). p.109-114(
- Contribution to journal › Article
- 2016
-
Mark
No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT
(
- Contribution to journal › Article
- 2014
-
Mark
Abstract P2-11-15: Immunohistochemical assessment of Ki67 with the antibodies SP6 and MIB1 - A comparison of prognostic information and reproducibility
(
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P2-10-07: Stem cell marker aldehyde dehydrogenase 1 in stromal cells strongly correlates with prognosis in breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
A Prognostic Index Composed of Progesterone Receptor Status, Tumour Size and S-phase Fraction, Predicts Survival in Node-Negative Breast Cancer Patients in a Large Multicentre Prospective Cohort Study.
(
- Contribution to journal › Published meeting abstract
-
Mark
Abstract P2-10-19: Are the mitotic factors Mitotic Activity Index (MAI) and Phosphohistone 3 (PPH3) stronger prognostic proliferation factors than Ki67 in node-negative breast cancer?
(
- Contribution to journal › Published meeting abstract
-
Mark
G protein-coupled estrogen receptor in the plasma membrane is prognostic in early breast cancer
(
- Contribution to journal › Published meeting abstract
- 2013
-
Mark
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
(
- Contribution to journal › Article
- 2011
-
Mark
COMPLICATIONS AFTER CYSTECTOMY AND ILEAL CONDUIT FOR BLADDER CANCER IS MORE COMMON IN SMALL VOLUME HOSPITALS
2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.43-43(
- Contribution to journal › Published meeting abstract
-
Mark
431 INITIAL BCG INSTILLATION IS UNDER-USED IN T1 BLADDER CANCER
2011) 26th Annual Congress of the European Association of Urology In European Urology Supplements 10(2). p.148-148(
- Contribution to journal › Published meeting abstract